Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can sanding make surgery scars disappear?

NCT ID NCT07233200

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 2 times

Summary

This study tests whether a procedure called dermabrasion, which sands the skin, can improve the appearance of scars from free flap reconstruction in the head and neck. Forty adults who had flap surgery at least three months ago will have half their scar treated and half left alone. Doctors will compare photos to see if the treated side looks better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dermabrasion (a device that sands the skin to improve scar appearance)
What this could lead to
If it works, this could offer a simple, non-surgical way to make free flap scars look better.
What could go wrong
This is a small, early-stage study with only 40 people. Results may not apply to everyone, and dermabrasion carries risks like infection or skin color changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 18 years or older. 2. History of successful free flap reconstruction with a cutaneous skin paddle in the head and neck region. 3. Patients with benign (eg. osteoradionecrosis, trauma) or malignant (eg. squamous cell carcinoma) diagnoses requiring free flap reconstruction. 4. Benign free flap patients must be a minimum 3 months post-operative to ensure flap maturity. Malignant free flap patients must be a minimum of 3 months post-operative or post-radiation with no further cancer treatment (eg. radiation, surgery, chemotherapy) planned at that time. 5. Flap skin paddle must be of sufficient size and external to allow for split-treatment design (minimum 4 cm in diameter). Donor site scar must also be sufficient size (minimum 6 cm in length) 6. Patients must have ability to provide informed consent. 7. Willingness and ability to comply with the treatment and follow-up schedule. Exclusion Criteria: 1. Inability to give informed consent. 2. Evidence of active flap or radiation skin complications (e.g., infection, partial necrosis, wound breakdown). 3. Completion of head and neck radiation therapy within 3 months of first dermabrasion treatment date. 4. Uncontrolled diabetes mellitus (HbA1c \> 8.0%). 5. Current antibiotic use or known immunocompromised state. 6. History of keloid formation or hypertrophic scarring. 7. Fitzpatrick skin type VI or higher (due to increased risk of pigmentary changes). 8. Use of isotretinoin medication within the past 3 month (known to induce photosensitivity). 9. Current use of blood thinners that cannot be safely paused. 10. Known photosensitivity disorders. 11. Active malignancy requiring ongoing treatment. 12. Inability or unwillingness to avoid sun exposure during the treatment period. 13. Inability to perform or adhere to prescribed wound care. 14. Inability or unwillingness to attend follow-up visits.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Scar conditions and fibrosis of skin are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.